KSHV MicroRNAs Repress Tropomyosin 1 and Increase Anchorage-Independent Growth and Endothelial Tube Formation. by Philippe Kieffer-Kwon, Christine Happel, Thomas S Uldrick, Dhivya Ramalingam, Joseph M Ziegelbauer

Get full text

Phase I Study of Subcutaneous Rituximab Hyaluronidase Combined With CHOP Chemotherapy for the Treatment of Diffuse Large B-Cell Lymphoma in Uganda by Manoj P. Menon, Henry Ddungu, Kelvin R. Mubiru, Scott V. Adams, Jacqueline Asea, Rosemary Namagembe, Prossy Namuli, Joyce Kambugu, Andrea M.H. Towlerton, Camille Puronen, Thomas S. Uldrick, Jackson Orem, Edus H. Warren

Get full text

Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma by Leonard D’Amico, Martin Cheever, Steven P Fling, Anna Wright, Kathryn Lurain, Ramya Ramaswami, Irene Ekwede, Thomas S Uldrick, Robert Yarchoan, Judith C Kaiser, Angela Shaulov Kask, Manoj P Menon, Paul Couey, Eli Burnham, Allysson Angeldekao, Byung Ha Lee, Li-Lian Kwok, Chia-Ching Jackie Wang

Get full text

Cancer immunotherapy clinical trials to support urgently needed access in low- and middle-income countries: a report from the SITC global access and impact committee by T Peter Kingham, Innocent Adoubi, Avery D Posey, Ahmad A Tarhini, David R Kaufman, Jyoti Bajpai, Solmaz Sahebjam, Mauricio Burotto, Verna Vanderpuye, Thomas S Uldrick, Olufunmilayo I Olopade, Thomas A Odeny, Wilfred Ngwa, Jennifer Dent, Micaella Jorge, Nora Sobrevilla, Huwaida Bulhan, Gideon T Dosunmu, Lilian Ekpo, Satish Gopal, Manuel R Espinoza-Gutarra, N’da Marcelin Homian, Clarissa Mathias, Nixon Niyonzima, Blaise Nkegoum, Regina Switzer

Get full text